ID
15569
Beschrijving
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Part: Baseline: Repitition of Assessments If already performed at screening, please enter results of screening MRI.
Link
https://clinicaltrials.gov/ct2/show/NCT02419378
Trefwoorden
Versies (3)
- 03-06-16 03-06-16 -
- 03-06-16 03-06-16 -
- 03-06-16 03-06-16 -
Geüploaded op
3 juni 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Baseline: Repitition of Assessments: MRI Multiple Sclerosis ALAIN01 NCT02419378
Baseline: Repitition of Assessments: MRI Multiple Sclerosis ALAIN01 NCT02419378
Similar models
Baseline: Repitition of Assessments: MRI Multiple Sclerosis ALAIN01 NCT02419378
C0011008 (UMLS CUI [1,2])
C0032976 (UMLS CUI [1,2])
C0032976 (UMLS CUI [1,2])
C1550373 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])
C1333400 (UMLS CUI [1,2])
C2700066 (UMLS CUI [1,2])
C2700066 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C2697938 (UMLS CUI [1,2])
C2697938 (UMLS CUI [1,2])
C1519316 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])